Metsera initiated with an Outperform at Evercore ISI
Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 ...
Evercore ISI Remains a Buy on Magnite (MGNI)
In a report released yesterday, Robert Coolbrith from Evercore ISI maintained a Buy rating on Magnite (MGNI – Research Report), with a price ...
Growth scare possibly unfolding ahead of Nvidia earnings, says Evercore ISI's Julian Emanuel
Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...
BioPharma Dive19h
Sanofi, Teva add to case for new bowel disease drug
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.